Cargando…

Diffuse Myocardial Fibrosis on Cardiac Magnetic Resonance Imaging Is Related to Galectin-3 and Predicts Outcome in Heart Failure

Aims: Ongoing adverse remodeling is a hallmark of heart failure (HF), which might be reflected by either focal or diffuse myocardial fibrosis. Therefore, in (pre)clinical settings, we used immunohistochemistry or cardiac magnetic resonance imaging (CMR) to investigate the association of (focal or di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Screever, Elles M., Gorter, Thomas M., Willems, Tineke P., Aboumsallem, Joseph Pierre, Suthahar, Navin, Mahmoud, Belend, van Veldhuisen, Dirk J., de Boer, Rudolf A., Meijers, Wouter C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046101/ https://www.ncbi.nlm.nih.gov/pubmed/36979345 http://dx.doi.org/10.3390/biom13030410

Ejemplares similares

Left atrial volume and left ventricular mass indices in heart failure with preserved and reduced ejection fraction
por: Gehlken, Carolin, et al.
Publicado: (2021)

From Inflammation to Fibrosis—Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities
por: Suthahar, Navin, et al.
Publicado: (2017)

Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update
por: Suthahar, Navin, et al.
Publicado: (2018)

Multifactorial Diseases of the Heart, Kidneys, Lungs, and Liver and Incident Cancer: Epidemiology and Shared Mechanisms
por: Shi, Canxia, et al.
Publicado: (2023)

Risk Factors for Immune Checkpoint Inhibitor–Mediated Cardiovascular Toxicities
por: Yousif, Laura I., et al.
Publicado: (2023)

Established Tumour Biomarkers Predict Cardiovascular Events and Mortality in the General Population
por: Bracun, Valentina, et al.
Publicado: (2021)

Fibrotic Marker Galectin-3 Identifies Males at Risk of Developing Cancer and Heart Failure
por: van den Berg, Pieter F., et al.
Publicado: (2023)

Galectin-3 in Cardiac Remodeling and Heart Failure
por: de Boer, Rudolf A., et al.
Publicado: (2010)

Erratum to: Galectin-3 in Cardiac Remodeling and Heart Failure
por: de Boer, Rudolf A., et al.
Publicado: (2012)

Galectin-3 and Blood Group: Binding Properties, Effects on Plasma Levels, and Consequences for Prognostic Performance
por: Pozder, Carolin, et al.
Publicado: (2023)

Clonal haematopoiesis of indeterminate potential: associations with heart failure incidence, clinical parameters and biomarkers
por: Shi, Canxia, et al.
Publicado: (2022)

Relative fat mass, a new index of adiposity, is strongly associated with incident heart failure: data from PREVEND
por: Suthahar, Navin, et al.
Publicado: (2022)

ST2 and Galectin-3: Ready for Prime Time?
por: Meijers, Wouter C., et al.
Publicado: (2016)

Relationship between body mass index, cardiovascular biomarkers and incident heart failure
por: Suthahar, Navin, et al.
Publicado: (2021)

Kidney Function in Patients With Neuromuscular Disease: Creatinine Versus Cystatin C
por: Screever, Elles M., et al.
Publicado: (2021)

Epicardial fat in heart failure patients with mid‐range and preserved ejection fraction
por: van Woerden, Gijs, et al.
Publicado: (2018)

Comorbidities complicating heart failure: changes over the last 15 years
por: Screever, Elles M., et al.
Publicado: (2022)

Epicardial Adipose Tissue and Outcome in Heart Failure With Mid-Range and Preserved Ejection Fraction
por: van Woerden, Gijs, et al.
Publicado: (2021)

Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
por: de Boer, Rudolf A, et al.
Publicado: (2011)

Cancer and heart disease: associations and relations
por: de Boer, Rudolf A., et al.
Publicado: (2019)

Circulating immune checkpoints predict heart failure outcomes
por: Screever, Elles M., et al.
Publicado: (2023)

Importance of epicardial adipose tissue localization using cardiac magnetic resonance imaging in patients with heart failure with mid‐range and preserved ejection fraction
por: van Woerden, Gijs, et al.
Publicado: (2021)

Sex differences in associations of comorbidities with incident cardiovascular disease: focus on absolute risk
por: Dronkers, Just, et al.
Publicado: (2022)

Reply: Imaging-Based Obesity Assessment for Risk Factor Stratification and Prognostication in Malignancy
por: Liu, Elizabeth E., et al.
Publicado: (2022)

A Genome-Wide Association Study of Circulating Galectin-3
por: de Boer, Rudolf A., et al.
Publicado: (2012)

Sex‐related differences in contemporary biomarkers for heart failure: a review
por: Suthahar, Navin, et al.
Publicado: (2020)

Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis
por: van Veldhuisen, Sophie L, et al.
Publicado: (2022)

In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy
por: Brouwer, Wessel P, et al.
Publicado: (2014)

Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study
por: Lok, Dirk J. A., et al.
Publicado: (2010)

Connecting epicardial adipose tissue and heart failure with preserved ejection fraction: mechanisms, management and modern perspectives
por: van Woerden, Gijs, et al.
Publicado: (2022)

A combined bioinformatics, experimental and clinical approach to identify novel cardiac‐specific heart failure biomarkers: is Dickkopf‐3 (DKK3) a possible candidate?
por: Piek, Arnold, et al.
Publicado: (2020)

Urinary albumin excretion and cancer risk: the PREVEND cohort study
por: Luo, Li, et al.
Publicado: (2023)

Prognostic value of galectin-3, a novel marker of fibrosis
por: Lok, Dirk J., et al.
Publicado: (2010)

Pulmonary regurgitant volume is superior to fraction using background-corrected phase contrast MRI in determining the severity of regurgitation in repaired tetralogy of Fallot
por: Gorter, Thomas M., et al.
Publicado: (2015)

Evaluation of renal cancer progression in a mouse model of heart failure
por: Shi, Canxia, et al.
Publicado: (2021)

Reverse Cardio‐Oncology: Cancer Development in Patients With Cardiovascular Disease
por: Aboumsallem, Joseph Pierre, et al.
Publicado: (2020)

Renal Handling of Galectin‐3 in the General Population, Chronic Heart Failure, and Hemodialysis
por: Meijers, Wouter C., et al.
Publicado: (2014)

Diffuse myocardial fibrosis in pediatric hypertrophic cardiomyopathy
por: Hussain, Tarique, et al.
Publicado: (2013)

The value of echocardiographic measurement of epicardial adipose tissue in heart failure patients
por: van Woerden, Gijs, et al.
Publicado: (2022)

Assessment of diffuse myocardial fibrosis in systemic sclerosis by cardiac magnetic resonance imaging
por: Lee, Daniel C, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2gtci52flusnvi13i2u9lbedp3